Morgan Stanley slashes price target on Amicus Therapeutics Inc [FOLD] – find out why.
Amicus Therapeutics Inc [NASDAQ: FOLD] closed the trading session at $10.43. The stocks have a year to date performance of -26.50 percent and weekly performance of -1.04 percent. The stock has been moved at -4.49 percent over the last six months. The stock has performed